AYTU BIOPHARMA INC (AYTU) Earnings History & Surprises
NASDAQ:AYTU • US0547548588
2.49 USD
-0.11 (-4.23%)
Last: Mar 11, 2026, 10:00 AM
Past quarterly earnings results for AYTU BIOPHARMA INC (AYTU), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMay 12, 2026
PeriodQ3 / 2026
EPS Estimate-$0.58
Revenue Estimate13.552M
Last Reported
Release DateFeb 3, 2026
PeriodQ2 / 2026
EPS Reported-$1.05
EPS Surprise -71.57%
Revenue Surprise 22.12%
Beat Rate
69%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | -1.05 | -0.61 | -71.57% | -303.85% | 15.165M | 12.418M | 22.12% | -6.51% |
| Q1 2026 | 0.21 | -0.23 | 189.51% | -52.27% | 13.888M | 12.645M | 9.83% | -14.38% |
| Q4 2025 | -2.92 | -0.04 | -7,706.78% | -256.10% | 15.135M | 18.28M | -17.20% | -15.80% |
| Q3 2025 | 0.21 | -0.17 | 221.11% | 140.38% | 18.452M | 14.014M | 31.67% | 2.55% |
| Q2 2025 | -0.26 | -0.29 | 8.96% | -550.00% | 16.221M | 15.865M | 2.24% | -29.27% |
| Q1 2025 | 0.44 | -0.35 | 226.87% | 129.73% | 16.221M | 14.043M | 15.51% | -26.60% |
| Q4 2024 | -0.82 | -0.46 | -78.65% | -38.98% | 17.976M | 18.667M | -3.70% | -41.51% |
| Q3 2024 | -0.52 | -0.65 | 20.34% | 73.06% | 17.993M | 17.693M | 1.70% | -20.85% |
| Q2 2024 | -0.04 | -0.26 | 84.31% | 96.95% | 22.934M | 22.18M | 3.40% | -12.73% |
| Q1 2024 | -1.48 | -0.04 | -3,527.45% | -23.33% | 22.099M | 28.281M | -21.86% | -20.10% |
| Q4 2023 | -0.59 | -0.97 | 39.11% | 93.98% | 30.732M | 28.248M | 8.79% | 11.96% |
| Q3 2023 | -1.93 | -0.64 | -200.34% | 94.61% | 22.733M | 28.56M | -20.40% | -6.06% |
| Q2 2023 | -1.31 | -1.63 | 19.73% | 85.11% | 26.28M | 26.928M | -2.41% | 13.62% |
| Q1 2023 | -1.20 | -3.67 | 67.32% | 94.50% | 27.66M | 24.786M | 11.60% | 26.30% |
| Q4 2022 | -9.80 | -7.55 | -29.84% | 34.67% | 27.45M | 26.01M | 5.54% | 16.91% |
| Q3 2022 | -35.80 | -8.36 | -328.02% | -26.95% | 24.2M | 25.296M | -4.33% | 79.53% |
| Q2 2022 | -8.80 | -11.83 | 25.63% | 37.14% | 23.13M | 27.744M | -16.63% | 52.67% |
| Q1 2022 | -21.80 | -10.00 | -118.09% | -172.50% | 21.9M | 22.542M | -2.85% | 61.98% |
| Q4 2021 | -15.00 | -10.00 | -50.06% | -275.00% | 23.48M | 21.318M | 10.14% | 58.01% |
| Q3 2021 | -28.20 | -6.43 | -338.84% | 6.00% | 13.48M | 14.346M | -6.04% | 65.20% |
| Q2 2021 | -14.00 | -8.98 | -55.97% | -600.00% | 15.15M | 12.495M | 21.25% | 376.42% |
| Q1 2021 | -8.00 | -11.22 | 28.70% | 87.50% | 13.52M | 13.597M | -0.57% | 838.89% |
| Q4 2020 | -4.00 | -7.14 | 43.98% | - | 14.86M | 11.465M | 29.61% | - |
| Q3 2020 | -30.00 | -44.88 | 33.16% | - | 8.16M | 6.533M | 24.90% | - |
| Q2 2020 | -2.00 | -49.98 | 96.00% | - | 3.18M | 2.792M | 13.90% | - |
| Q1 2020 | -64.00 | -56.10 | -14.08% | - | 1.44M | 2.055M | -29.93% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-1,841.93%
Max EPS beat (4)
221.11%
Min EPS beat (4)
-7,706.78%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
11.60%
Max Revenue beat (4)
31.67%
Min Revenue beat (4)
-17.20%
Analysis
In the last 4 quarters, AYTU has beaten EPS estimates in 2 out of 4 releases
AYTU has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, AYTU reported -1841.9% below the EPS estimates on average.
In the last 4 quarters, AYTU has beaten the revenue estimates by 11.6% on average.
AYTU BIOPHARMA INC / AYTU Earnings FAQ
Can you provide the last earnings date for AYTU BIOPHARMA INC?
AYTU BIOPHARMA INC (AYTU) last reported earnings on 2/3/2026.
Can you provide information on whether AYTU BIOPHARMA INC beat earnings estimates in the last quarter?
AYTU BIOPHARMA INC (AYTU) missed EPS estimates and beat revenue estimates in the most recent quarter.
How often does AYTU BIOPHARMA INC (AYTU) beat earnings estimates?
In the last 4 quarters, AYTU BIOPHARMA INC (AYTU) has beaten EPS estimates in 2 out of 4 releases.